Wells Fargo & Company Issues Pessimistic Forecast for Agilent Technologies (NYSE:A) Stock Price

Agilent Technologies (NYSE:A) had its price objective decreased by equities researchers at Wells Fargo & Company from $165.00 to $160.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the medical research company’s stock. Wells Fargo & Company‘s price objective points to a potential upside of 18.71% from the stock’s current price.

A number of other analysts have also commented on A. Wall Street Zen lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Royal Bank Of Canada started coverage on shares of Agilent Technologies in a research report on Wednesday. They set an “outperform” rating and a $153.00 price target on the stock. Barclays reduced their price objective on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. UBS Group lowered their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Finally, Morgan Stanley dropped their target price on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $160.73.

Agilent Technologies Stock Up 16.4%

NYSE A traded up $18.95 on Thursday, reaching $134.79. The company had a trading volume of 1,630,510 shares, compared to its average volume of 2,183,910. The company’s fifty day moving average is $114.99 and its 200-day moving average is $128.79. The firm has a market capitalization of $38.09 billion, a price-to-earnings ratio of 29.65, a price-to-earnings-growth ratio of 2.42 and a beta of 1.22. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. Agilent Technologies has a 1-year low of $108.35 and a 1-year high of $160.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.84 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The company’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter last year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts forecast that Agilent Technologies will post 5.95 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of A. Core Wealth Advisors LLC bought a new position in Agilent Technologies during the fourth quarter worth about $26,000. SHP Wealth Management bought a new stake in Agilent Technologies in the fourth quarter valued at approximately $26,000. Board of the Pension Protection Fund bought a new position in shares of Agilent Technologies during the 4th quarter worth approximately $27,000. Navalign LLC acquired a new position in shares of Agilent Technologies during the 4th quarter worth approximately $27,000. Finally, Cedar Mountain Advisors LLC bought a new stake in Agilent Technologies in the 1st quarter valued at $27,000.

Key Stories Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent beat Wall Street’s Q2 expectations, reporting adjusted EPS of $1.49 versus estimates around $1.41 and revenue of $1.83 billion, above forecasts, with revenue up 10% year over year. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its full-year 2026 profit outlook and also issued Q3 guidance that points to continued growth, reinforcing confidence in demand for its lab tools and diagnostic products. Agilent raises 2026 profit forecast on strong demand for lab tools
• Positive Sentiment: Bank of America upgraded Agilent from neutral to buy, which typically helps sentiment because it signals improved confidence in the stock’s upside. Benzinga report on Bank of America upgrade
• Positive Sentiment: RBC also initiated coverage with an outperform rating and a $153 price target, adding another bullish analyst call after earnings. Benzinga report on RBC coverage
• Neutral Sentiment: Agilent also highlighted new product launches and digital-lab tools, including OpenLab Sync and new GC systems, which support the longer-term growth story but are less likely to move the stock immediately. Agilent Introduces OpenLab Sync

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.